Sfoglia per Rivista  

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 19 a 32 di 32
Titolo Data di pubblicazione Autore(i) File
PERSPECTIVES ON ANTHRACYCLINES PLUS IFOSFAMIDE IN ADVANCED SOFT-TISSUE SARCOMAS 1-gen-1993 Casali, P; Pastorino, U; Azzarelli, A; Bertulli, R; Zucchinelli, P; Devizzi, L; Santoro, A
Pharmacodynamic effects in the cerebrospinal fluid of rats after intravenous administration of different asparaginase formulations 1-gen-2017 Ballerini, A; Moro, F; Nerini, If; Marzo, Cm; Di Clemente, A; Ferrari, M; D'Incalci, M; Biondi, A; Colombini, A; Conter, V; Porcu, L; Cervo, L; Rizzari, C; Zucchetti, M
Pharmacokinetic and pharmacodynamic study of doxorubicin in children with cancer: results of a "European Pediatric Oncology Off-patents Medicines Consortium" trial 1-gen-2016 Krischke, M; Hempel, G; Voller, S; Andre, N; D'Incalci, M; Bisogno, G; Kopcke, W; Borowski, M; Herold, R; Boddy, Av; Boos, J
Pharmacokinetic profile of imatinib mesylate and N-desmethyl-imatinib (CGP 74588) in children with newly diagnosed Ph plus acute leukemias 1-gen-2009 Marangon, E; Citterio, M; Sala, F; Barisone, E; Lippi, Aa; Rizzari, C; Biondi, A; D'Incalci, M; Zucchetti, M
Pharmacokinetics and antineoplastic activity of galectin-1-targeting OTX008 in combination with sunitinib 1-gen-2013 Zucchetti, M; Bonezzi, K; Frapolli, R; Sala, F; Borsotti, P; Zangarini, M; Cvitkovic, E; Noel, K; Ubezio, P; Giavazzi, R; D'Incalci, M; Taraboletti, G
The pharmacokinetics of liposomal encapsulated daunorubicin are not modified by HAART in patients with HIV-associated Kaposi's sarcoma 1-gen-2000 Fumagalli, L; Zucchetti, M; Parisi, I; Viganò, M G; Zecca, B; Careddu, A; D'Incalci, M; Lazzarin, A
Phase I clinical and pharmacological study of oral methoxymorpholinyl doxorubicin (PNU 152243) 1-gen-1999 Sessa, C; Zucchetti, M; Ghielmini, M; Bauer, J; D'Incalci, M; de Jong, J; Naegele, H; Rossi, S; Pacciarini, Ma; Domenigoni, L; Cavalli, F
Phase II trial of salvage therapy with trabectedin in metastatic pancreatic adenocarcinoma 1-gen-2016 Belli, C; Piemonti, L; D'Incalci, M; Zucchetti, M; Porcu, L; Cappio, S; Doglioni, C; Allavena, P; Ceraulo, D; Maggiora, P; Dugnani, E; Cangi, Mg; Garassini, G; Reni, M
Preliminary safety evaluation of the putative cancer chemopreventive agent tricin, a naturally occurring flavone 1-gen-2006 Verschoyle, Re; Greaves, P; Cai, H; Arndt, B; Broggini, M; D'Incalci, M; Riccio, E; Doppalapudi, R; Kapetanovic, Im; Steward, Wp; Gescher, Aj
PREOPERATIVE DOXORUBICIN PLUS IFOSFAMIDE IN PRIMARY SOFT-TISSUE SARCOMAS OF THE EXTREMITIES 1-gen-1993 Azzarelli, A; Quagliuolo, V; Casali, P; Fissi, S; Montalto, F; Santoro, A
Relationship of promising methods in the detection of anthracycline-induced cardiotoxicity in breast cancer patients 1-gen-2015 Bulten, Bf; Verberne, Hj; Bellersen, L; Oyen, W; Sabate-Llobera, A; Mavinkurve-Groothuis, Amc; Kapusta, L; van Laarhoven, Hwm; de Geus-Oei, Lf
Targeting the EWS-FLI1 transcription factor in Ewing sarcoma 1-gen-2015 Tancredi, R; Zambelli, A; Daprada, G A; Fregoni, V; Pavesi, L; Riccardi, A; Burdach, S; Grohar, P J; D'Incalci, M
Tyrosine kinase inhibitors and multidrug resistance proteins: interactions and biological consequences 1-gen-2010 Azzariti, A; Porcelli, L; Simone, Gm; Quatrale, Ae; Colabufo, Na; Berardi, F; Perrone, R; Zucchetti, M; D'Incalci, M; Xu, Jm; Paradiso, A
Unique features of trabectedin mechanism of action 1-gen-2016 Larsen, Ak; Galmarini, Cm; D'Incalci, M
Mostrati risultati da 19 a 32 di 32
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile